Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Kagiampakis

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|January 18, 2008
An information measure of the quality of protein secondary structure predictionRosemarie Swanson, Ioannis Kagiampakis, Jerry W Tsai
Proteins|September 2, 2009
Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTESHongjun Jin, Ioannis Kagiampakis, Pingwei Li, et al.
Bioinformatics (Oxford, England)|November 16, 2006
Detecting protein dissimilarities in multiple alignments using Bayesian variable selectionSinae Kim, Jerry Tsai, Ioannis Kagiampakis, et al.
Biochemistry|September 25, 2007
Nickel-dependent oligomerization of the alpha subunit of acetyl-coenzyme a synthase/carbon monoxide dehydrogenaseXiangshi Tan, Ioannis Kagiampakis, Ivan V Surovtsev, et al.
Biochemistry|September 11, 2008
Conservation of unfavorable sequence motifs that contribute to the chemokine quaternary stateIoannis Kagiampakis, Hongjun Jin, Sinae Kim, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2013
The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanismJie Xue, Bart Hoorelbeke, Ioannis Kagiampakis, et al.
Nature Communications|March 2, 2025
Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkersGustavo Arango-Argoty, Elly Kipkogei, Ross Stewart, et al.
Molecular Pharmaceutics|July 26, 2012
The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsinJie Xue, Yongguang Gao, Bart Hoorelbeke, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41Ioannis Kagiampakis, Arbi Gharibi, Marie K Mankowski, et al.
Journal of Translational Medicine|August 5, 2024
Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancerChao Fang, Gustavo Alonso Arango Argoty, Ioannis Kagiampakis, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|January 18, 2008
An information measure of the quality of protein secondary structure predictionRosemarie Swanson, Ioannis Kagiampakis, Jerry W Tsai
Proteins|September 2, 2009
Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTESHongjun Jin, Ioannis Kagiampakis, Pingwei Li, et al.
Bioinformatics (Oxford, England)|November 16, 2006
Detecting protein dissimilarities in multiple alignments using Bayesian variable selectionSinae Kim, Jerry Tsai, Ioannis Kagiampakis, et al.
Biochemistry|September 25, 2007
Nickel-dependent oligomerization of the alpha subunit of acetyl-coenzyme a synthase/carbon monoxide dehydrogenaseXiangshi Tan, Ioannis Kagiampakis, Ivan V Surovtsev, et al.
Biochemistry|September 11, 2008
Conservation of unfavorable sequence motifs that contribute to the chemokine quaternary stateIoannis Kagiampakis, Hongjun Jin, Sinae Kim, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2013
The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanismJie Xue, Bart Hoorelbeke, Ioannis Kagiampakis, et al.
Nature Communications|March 2, 2025
Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkersGustavo Arango-Argoty, Elly Kipkogei, Ross Stewart, et al.
Molecular Pharmaceutics|July 26, 2012
The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsinJie Xue, Yongguang Gao, Bart Hoorelbeke, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41Ioannis Kagiampakis, Arbi Gharibi, Marie K Mankowski, et al.
Journal of Translational Medicine|August 5, 2024
Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancerChao Fang, Gustavo Alonso Arango Argoty, Ioannis Kagiampakis, et al.
Pageof 3